CorVel stock hits 52-week low at 93.21 USD

Published 18/07/2025, 20:40
CorVel stock hits 52-week low at 93.21 USD

CorVel Corp’s stock recently reached a 52-week low, touching a price of 93.21 USD. According to InvestingPro data, technical indicators suggest the stock is in oversold territory, while the company maintains a "GREAT" overall financial health score. This milestone comes amidst a challenging year for the company, though it has actually posted a 3.47% gain over the past year. Despite current pressures, CorVel maintains strong fundamentals with a 23.4% gross profit margin and operates with a moderate debt level, as revealed by its 0.09 debt-to-equity ratio. Investors are closely monitoring the company’s performance and market conditions to assess future prospects. The company’s revenue grew by 12.6% in the last twelve months, though current analysis suggests the stock may be overvalued. For deeper insights and access to 12 additional ProTips about CorVel, consider exploring the comprehensive Pro Research Report available on InvestingPro.

In other recent news, CorVel Corp reported a 12% increase in revenue for Q4 2025, reaching $232 million, and a significant 38% rise in earnings per share (EPS) to $0.51. Despite these strong financial results, the company’s stock experienced a decline, which may reflect investor concerns about future growth prospects. For the fiscal year, CorVel’s revenues were $896 million, marking a 13% increase, while the EPS rose 24% to $1.83. The company continues to focus on AI integration and operational efficiency, contributing to its robust performance. Notably, the network solutions segment saw a 24% increase in revenue, highlighting the company’s strategic advancements in this area. Analysts have noted CorVel’s strong financial position, with a debt-free balance sheet that supports improved earnings. The company is also investing in AI technologies to enhance service offerings and maintain competitiveness in the healthcare sector. These developments underscore CorVel’s commitment to innovation and strategic growth.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.